Damien Duveau

2.4k total citations · 1 hit paper
23 papers, 1.2k citations indexed

About

Damien Duveau is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Damien Duveau has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Organic Chemistry and 7 papers in Immunology. Recurrent topics in Damien Duveau's work include Glycosylation and Glycoproteins Research (6 papers), Galectins and Cancer Biology (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Damien Duveau is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Galectins and Cancer Biology (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Damien Duveau collaborates with scholars based in United States, United Kingdom and Norway. Damien Duveau's co-authors include Craig J. Thomas, Suzanne Walker, Michael B. Lazarus, John Janetzko, Sara E. Martin, Lydia Tam, Jing Ni, Shawn Gillespie, Jean J. Zhao and James Lennon and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Damien Duveau

23 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma

2017 352 citations Humsa S. Venkatesh, Lydia Tam et al. Nature profile →

Peers

Countries citing papers authored by Damien Duveau

Since Specialization

Citations

This map shows the geographic impact of Damien Duveau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Duveau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Duveau more than expected).

Fields of papers citing papers by Damien Duveau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Duveau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Duveau. The network helps show where Damien Duveau may publish in the future.

Co-authorship network of co-authors of Damien Duveau

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Duveau. A scholar is included among the top collaborators of Damien Duveau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Duveau. Damien Duveau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Compromised CDK12 activity causes dependency on the high activity of O-GlcNAc transferase 2024 ·Glycobiology ·(unknown), (unknown), (unknown), Jing Liang, (unknown), Damien Duveau, Helmut Pospiech, Craig J. Thomas, Massimo Loda, Harri M. Itkonen	2
2	CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations 2023 ·Cancer Research ·William C. Reinhold, Kelli M. Wilson, Fathi Elloumi, Katie R. Bradwell, Michele Ceribelli, Sudhir Varma, (unknown), Damien Duveau, (unknown), Jane B. Trepel, (unknown), Carleen Klumpp‐Thomas, (unknown), Paul Shinn, Augustin Luna, Craig J. Thomas, Yves Pommier	12
3	The Remarkable Selectivity of Nirmatrelvir 2022 ·ACS Pharmacology & Translational Science ·Damien Duveau, Craig J. Thomas	20
4	Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9 2020 ·Molecular Cancer Research ·Harri M. Itkonen, Ninu Poulose, Rebecca E. Steele, Sara E. Martin, Zebulon G. Levine, Damien Duveau, (unknown), Reema Singh, Alfonso Urbanucci, Massimo Loda, Craig J. Thomas, Ian G. Mills, Suzanne Walker	41
5	O-GlcNAc regulates gene expression by controlling detained intron splicing 2020 ·Nucleic Acids Research ·(unknown), (unknown), João A. Paulo, Stanislav Bellaousov, Sara E. Martin, Damien Duveau, Craig J. Thomas, Steven P. Gygi, Paul L. Boutz, Suzanne Walker	76
6	EWS-FLI1–regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth 2020 ·Molecular Cancer Therapeutics ·Sameer H. Issaq, Arnulfo Mendoza, (unknown), (unknown), Damien Duveau, Christine M. Heske, Jason M. Rohde, Matthew B. Boxer, Craig J. Thomas, Ralph J. DeBerardinis, Lee J. Helman	25
7	A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology 2020 ·PLoS ONE ·Teresa L. Burgess, (unknown), Jeffrey S. Rubin, Damien Duveau, Laurence Lamy, David D. Roberts, Catherine L. Farrell, James Inglese, Craig J. Thomas, Thomas W. Miller	19
8	Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors 2018 ·Journal of the American Chemical Society ·Sara E. Martin, (unknown), Harri M. Itkonen, Damien Duveau, João A. Paulo, John Janetzko, Paul L. Boutz, (unknown), (unknown), Craig J. Thomas, Steven P. Gygi, Michael B. Lazarus, Suzanne Walker	122
9	Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma 2017 ·Clinical Cancer Research ·Christine M. Heske, Mindy I. Davis, Joshua T. Baumgart, Kelli M. Wilson, Michael V. Gormally, Lu Chen, Xiaohu Zhang, Michele Ceribelli, Damien Duveau, Rajarshi Guha, Marc Ferrer, Fernanda I. Arnaldez, Jiuping Ji, (unknown), Yiping Zhang, Arnulfo Mendoza, Lee J. Helman, Craig J. Thomas	50
10	Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma breakdown → 2017 ·Nature ·Humsa S. Venkatesh, Lydia Tam, Pamelyn J. Woo, James Lennon, Surya Nagaraja, Shawn Gillespie, Jing Ni, Damien Duveau, Patrick J. Morris, Jean J. Zhao, Craig J. Thomas, Michelle Monje	352
11	Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism 2016 ·Oncotarget ·Harri M. Itkonen, (unknown), Damien Duveau, Sara E. Martin, Anna Barkovskaya, Tone F. Bathen, Siver Andreas Moestue, Ian G. Mills	79
12	Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia 2015 ·Retrovirology ·Meili Zhang, Lesley A. Mathews Griner, Lili Ju, Damien Duveau, Rajarshi Guha, Michael Petrus, Bernard Wen, Michiyuki Maeda, Paul Shinn, Marc Ferrer, Kevin C. Conlon, Richard N. Bamford, John J. O’Shea, Craig J. Thomas, Thomas A. Waldmann	5
13	Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2–dependent adult T-cell leukemia 2015 ·Proceedings of the National Academy of Sciences ·Meili Zhang, Lesley A. Mathews Griner, Lili Ju, Damien Duveau, Rajarshi Guha, Michael Petrus, Bernard Wen, Michiyuki Maeda, Paul Shinn, Marc Ferrer, Kevin Conlon, Richard N. Bamford, John J. O’Shea, Craig J. Thomas, Thomas A. Waldmann	77
14	A Small Molecule That Inhibits OGT Activity in Cells 2015 ·ACS Chemical Biology ·Rodrigo F. Ortiz‐Meoz, Jiaoyang Jiang, Michael B. Lazarus, Marina Orman, John Janetzko, Chenguang Fan, Damien Duveau, (unknown), Craig J. Thomas, Suzanne Walker	204
15	Structure–activity relationship studies and biological characterization of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Damien Duveau, Adam Yasgar, Yuhong Wang, Xin Hu, Jennifer Kouznetsova, Kyle R. Brimacombe, Ajit Jadhav, Anton Simeonov, Craig J. Thomas, David J. Maloney	13
16	Synthesis and biological evaluation of analogues of the kinase inhibitor nilotinib as Abl and Kit inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Damien Duveau, Xin Hu, Martin J. Walsh, Suneet Shukla, Amanda P. Skoumbourdis, Matthew B. Boxer, Suresh V. Ambudkar, Min Shen, Craig J. Thomas	18
17	Synthesis and characterization of mitoQ and idebenone analogues as mediators of oxygen consumption in mitochondria 2010 ·Bioorganic & Medicinal Chemistry ·Damien Duveau, (unknown), Robert Schoenfeld, (unknown), Gino Cortopassi, Sidney M. Hecht	36
18	Preparation of β-phenylnitroethanes having electron-donating aryl substitution 2007 ·Tetrahedron Letters ·Frederick A. Luzzio, Marek T. Włodarczyk, Damien Duveau, (unknown)	5
19	A Chiral Pool Approach toward the Synthesis of Thalidomide Metabolites 2006 ·Heterocycles ·Frederick A. Luzzio, Damien Duveau, William D. Figg	4
20	Synthesis of Racemic cis-5-Hydroxy-3-phthalimidoglutarimide. A Metabolite of Thalidomide Isolated from Human Plasma 2005 ·The Journal of Organic Chemistry ·Frederick A. Luzzio, Damien Duveau, Erin R. Lepper, William D. Figg	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact